help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 13, 2004
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1640
A more recent version of this article appeared on January 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/1/6    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akamizu, T.
Right arrow Articles by Kangawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akamizu, T.
Right arrow Articles by Kangawa, K.

Submitted on August 17, 2004
Accepted on October 1, 2004

Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay

Takashi Akamizu*, Toshiaki Shinomiya, Taiga Irako, Mikihiko Fukunaga, Yoshihide Nakai, Yoshikatsu Nakai, and Kenji Kangawa

Ghrelin Research Project, Department of Experimental Therapeutics, Translational Research Center, Kyoto University Hospital (T.A., T.I., K.K.), and School of Health Sciences (Yoshik.N.), Faculty of Medicine, Kyoto University, Kyoto 606-8507; Department of Psychosomatic Internal Medicine, Kansai Medical University (T.S., M.F., Yoshih.N.), Osaka 570-8506; and Department of Biochemistry, National Cardiovascular Center Research Institute (K.K.), Osaka 565-8565, Japan

* To whom correspondence should be addressed.
Takashi Akamizu, E-mail: akamizu{at}kuhp.kyoto-u.ac.jp

Two forms of ghrelin, acylated and desacyl, circulate in plasma. Although acylation is thought to be essential for ghrelin biological activities, recent studies have suggested that desacyl ghrelin may also possess biological activity. A new commercial ELISA system has now enabled us to measure plasma levels of each of these two ghrelin forms separately. This assay system directly measures levels using small amounts of plasma. To evaluate the utility of this assay system, we measured the plasma levels of the two forms of ghrelin in healthy volunteers. Although acylated ghrelin levels were equivalent to those measured previously by RIA, desacyl ghrelin levels were lower than those expected from the total ghrelin levels previously determined by RIA. The ratios of acylated to desacyl ghrelin significantly correlated with previously determined acylated, but not desacyl, ghrelin levels. After BMI adjustment, the levels of acylated, but not desacyl, ghrelin plasma levels were higher in female subjects than those in males. Several metabolic and hormonal parameters significantly correlated with either plasma acylated or desacyl ghrelin levels. These findings indicate that separate measurements of the two ghrelin form levels may provide valuable information on their structure, gender differences, and physiological implications.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society